FSH

5 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
Ganirelix acetate injection (Orgalutran)	Organon & Co. (OGN)

Phase 3(3)

Drug	Company
aoc 1020	Avidity Biosciences, Inc. (RNAM)
losmapimod	Fulcrum Therapeutics, Inc. (FULC)
srp-1001	Sarepta Therapeutics, Inc. (SRPT)

Preclinical(1)

Drug	Company
FSHD program candidate	Dyne Therapeutics, Inc. (DYN)

BioSniper tracks 5 drugs in development for FSH across 5 companies.

There are 1 clinical trial targeting FSH tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.